Plaintiffs in valsartan-based drug lawsuits filed over possible carcinogenic contamination may have to make room for additional consumers as lawyers push for the inclusion of two other blood pressure medications, losartan and irbesartan. Batches of the drugs, in addition to valsartan, have been found to be tainted with NDMA, or nitrosodimethylamine. NDMA is a known human carcinogen and has been linked to the development of certain ...
NDMA Contamination Found in Additional Blood Pressure and Diabetes Medications
Posted January 10, 2020 in Drug and Medical Device Lawsuits | Product News and Recalls
Contamination Leads to Cancer Risk in Another Heart Medication
Posted November 15, 2018 in Drug and Medical Device Lawsuits | Product News and Recalls
When several heart medications were found to be contaminated with varying levels of two compounds that are suspected of being human carcinogens, most reports confidently named valsartan as the culprit. Several lots of medications containing valsartan manufactured primarily in Chinese laboratories were found to contain trace amounts of compounds known as NDMA and NDEA. Subsequent testing lead to recalls being issued in both the United States and Canada while ...
